FDA inspection

New York Blood Center Enterprises: FDA inspection ending Nov 9, 2020

FDA inspection 1132683 · Voluntary Action Indicated (VAI) · Melville, NY

Key facts

Inspection ID 1132683
Firm New York Blood Center Enterprises
FEI number 3003490413
Address 905 Walt Whitman Rd
City Melville
State NY
ZIP 11747
Country United States
Fiscal year 2021
Inspection end date Nov 9, 2020
Classification Voluntary Action Indicated (VAI)
Project area Human Cellular, Tissue, and Gene Therapies
Product type Biologics

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections